Identifying Clinicoradiological Phenotypes in Diffuse Idiopathic Skeletal Hyperostosis: A Cross-Sectional Study
Abstract
:1. Introduction
2. Methods
3. Statistical Analysis
4. Results
5. Discussion
6. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Acknowledgments
Conflicts of Interest
References
- Forestier, J.; Rotes-Querol, J. Senile Ankylosing Hyperostosis of the Spine. Ann. Rheum. Dis. 1950, 9, 321–330. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Resnick, D.; Shaul, S.R.; Robins, J.M. Diffuse idiopathic skeletal hyperostosis (DISH): Forestier’s disease with extraspinal manifestations. Radiology 1975, 115, 513–524. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Mader, R.; Sarzi-Puttini, P.; Atzeni, F.; Olivieri, I.; Pappone, N.; Verlaan, J.-J.; Buskila, D. Extraspinal manifestations of diffuse idiopathic skeletal hyperostosis. Rheumatology 2009, 48, 1478–1481. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Resnick, D.; Niwayama, G. Radiographic and Pathologic Features of Spinal Involvement in Diffuse Idiopathic Skeletal Hyperostosis (DISH). Radiology 1976, 119, 559–568. [Google Scholar] [CrossRef] [PubMed]
- Clavaguera, T.; Reyner, P.; Valls, R.; de Cendra, E.; Rodríguez-Jimeno, M.C. Diffuse idiopathic skeletal hyperostosis: Can we identify a peripheral pattern? Reum. Clin. 2019, 15, 301–304. [Google Scholar] [CrossRef]
- Lee, W.; Kim, W.R.; Chang, M.C. Severe hip joint motion restriction in a patient with diffuse idiopathic skeletal hyperostosis: A case report. Medicine 2018, 97, e0652. [Google Scholar] [CrossRef]
- Hwang, J.; Hwang, D.-S.; Kang, C.; Lee, W.-Y.; Lee, G.-S.; Lee, J.-K.; Kim, Y.-K. Arthroscopic Treatment for Femoroacetabular Impingement with Extraspinal Diffuse Idiopathic Skeletal Hyperostosis. Clin. Orthop. Surg. 2019, 11, 275–281. [Google Scholar] [CrossRef]
- Bregeon, C.; Chevalier, J.; Bigorgne, J.C.; Renier, J.C. Ankylosing vertebral hyperostosis. Etiological investigations and search for a hypersecretion of growth hormone. Rev. Du Rhum. Mal. Osteo-Articul. 1973, 40, 319–327. [Google Scholar]
- Rogers, J.; Watt, I.; Dieppe, P. Palaeopathology of spinal osteophytosis, vertebral ankylosis, ankylosing spondylitis, and vertebral hyperostosis. Ann. Rheum. Dis. 1985, 44, 113–120. [Google Scholar] [CrossRef] [Green Version]
- Utsinger, P.D. Diffuse idiopathic skeletal hyperostosis. Clin. Rheum. Dis. 1985, 11, 325–351. [Google Scholar] [CrossRef]
- Kuperus, J.S.; de Gendt, E.E.A.; Oner, F.C.; de Jong, P.A.; Buckens, S.C.F.M.; van der Merwe, A.E. Classification criteria for diffuse idiopathic skeletal hyperostosis: A lack of consensus. Rheumatology 2017, 56, 1123–1134. [Google Scholar] [CrossRef] [Green Version]
- Crubézy, E.; Crubézy-Ibanez, E. Evaluation of diagnostic criteria for hyperostotic diseases on a series of skeletons. Epidemiological implications. Rev. Du Rhum. 1993, 60, 586–590. [Google Scholar]
- Mader, R.; Buskila, D.; Verlaan, J.-J.; Atzeni, F.; Olivieri, I.; Pappone, N.; Di Girolamo, C.; Sarzi-Puttini, P. Developing new classification criteria for diffuse idiopathic skeletal hyperostosis: Back to square one. Rheumatology 2012, 52, 326–330. [Google Scholar] [CrossRef] [Green Version]
- Kuperus, J.S.; Oudkerk, S.F.; Foppen, W.; Hoesein, F.A.M.; Gielis, W.P.; Waalwijk, J.; Regan, E.A.; Lynch, D.A.; Oner, F.C.; De Jong, P.A.; et al. Criteria for Early-Phase Diffuse Idiopathic Skeletal Hyperostosis: Development and Validation. Radiology 2019, 291, 420–426. [Google Scholar] [CrossRef]
- Vandenbroucke, J.P.; von Elm, E.; Altman, D.G.; Gøtzsche, P.C.; Mulrow, C.D.; Pocock, S.J. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and elaboration. Int. J. Surg. 2014, 12, 1500–1524. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Resnick, D. Diffuse Idiopathic Skeletal Hyperostosis (DISH). In Bone and Joint Imaging; Resnick, M.D., Ed.; W.B Saunders Company: Philadelphia, PA, USA, 2005; pp. 378–387. [Google Scholar]
- Aydin, S.Z.; Can, M.; Alibaz-Oner, F.; Keser, G.; Kurum, E.; Inal, V.; Yazisiz, V.; Birlik, M.; Emmungil, H.; Atagündüz, M.P.; et al. A relationship between spinal new bone formation in ankylosing spondylitis and the sonographically determined Achilles tendon enthesophytes. Rheumatol. Int. 2015, 36, 397–404. [Google Scholar] [CrossRef]
- Mata, S.; Chhem, R.K.; Fortin, P.R.; Joseph, L.; Esdaile, J.M. Comprehensive radiographic evaluation of diffuse idiopathic skeletal hyperostosis: Development and interrater reliability of a scoring system. Semin. Arthritis Rheum. 1998, 28, 88–96. [Google Scholar] [CrossRef]
- Guldberg-Møller, J.; Terslev, L.; Nielsen, S.M.; Kønig, M.J.; Torp-Pedersen, S.T.; Torp-Pedersen, A.; Christensen, R.; Bliddal, H.; Ellegaard, K. Ultrasound pathology of the entheses in an age and gender stratified sample of healthy adult subjects: A prospective cross-sectional frequency study. Clin. Exp. Rheumatol. 2018, 37, 408–413. [Google Scholar]
- Hermann, K.G.A.; Bollow, M. Rethinking diffuse idiopathic skeletal hyperostosis. Rheumatology 2014, 53, 1917–1919. [Google Scholar] [CrossRef] [Green Version]
- Mader, R. Diffuse idiopathic skeletal hyperostosis: Time for a change. J. Rheumatol. 2008, 35, 377–379. [Google Scholar]
- Mader, R.; Verlaan, J.-J.; Eshed, I.; Jacome, B.-A.; Puttini, P.S.; Atzeni, F.; Buskila, D.; Reinshtein, E.; Novofastovski, I.; Fawaz, A.; et al. Diffuse idiopathic skeletal hyperostosis (DISH): Where we are now and where to go next. RMD Open 2017, 3, e000472. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Mata, S.; Fortin, P.R.; Fitzcharles, M.-A.; Starr, M.R.; Joseph, L.; Watts, C.S.; Gore, B.; Rosenberg, E.; Chhem, R.K.; Esdaile, J.M. A Controlled Study of Diffuse Idiopathic Skeletal Hyperostosis Clinical Features and Functional Status. Medicine 1997, 76, 104–117. [Google Scholar] [CrossRef] [PubMed]
- Kagotani, R.; Yoshida, M.; Muraki, S.; Oka, H.; Hashizume, H.; Yamada, H.; Enyo, Y.; Nagata, K.; Ishimoto, Y.; Teraguchi, M.; et al. Prevalence of diffuse idiopathic skeletal hyperostosis (DISH) of the whole spine and its association with lumbar spondylosis and knee osteoarthritis: The ROAD study. J. Bone Miner. Metab. 2014, 33, 221–229. [Google Scholar] [CrossRef] [PubMed]
- Kim, B.S.; Moon, M.S.; Yoon, M.G.; Kim, S.T.; Kim, S.J.; Kim, M.S.; Kim, D.S. Prevalence of Diffuse Idiopathic Skeletal Hyperostosis Diagnosed by Whole Spine Computed Tomography: A Preliminary Study. Clin. Orthop. Surg. 2018, 10, 41–46. [Google Scholar] [CrossRef] [Green Version]
- Lee, W.; Reveille, J.D.; Davis, J.C.; Learch, T.J.; Ward, M.M.; Weisman, M.H. Are there gender differences in severity of ankylosing spondylitis? Results from the PSOAS cohort. Ann. Rheum. Dis. 2007, 66, 633–638. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Castro, R.O.; Ugalde, P.F.; Villegas, M.C.C.; Gutiérrez, J.C.; Gomariz, E.M.; Montejo, P.Z.; Almodóvar, R.; Mendoza, J.M.; Torre-Alonso, J.C.; Masmitjá, J.G.; et al. Different clinical expression of patients with ankylosing spondylitis according to gender in relation to time since onset of disease. Data from REGISPONSER. Reumatol. Clin. 2013, 9, 221–225. [Google Scholar]
- Mader, R.; Verlaan, J.-J.; Buskila, D. Diffuse idiopathic skeletal hyperostosis: Clinical features and pathogenic mechanisms. Nat. Rev. Rheumatol. 2013, 9, 741–750. [Google Scholar] [CrossRef]
- Kiss, C.; Szilágyi, M.; Paksy, A.; Poór, G. Risk factors for diffuse idiopathic skeletal hyperostosis: A case–control study. Rheumatology 2002, 41, 27–30. [Google Scholar] [CrossRef] [Green Version]
- Mader, R.; Novofestovski, I.; Adawi, M.; Lavi, I. Metabolic Syndrome and Cardiovascular Risk in Patients with Diffuse Idiopathic Skeletal Hyperostosis. Semin. Arthritis Rheum. 2009, 38, 361–365. [Google Scholar] [CrossRef]
- Pillai, S.; Littlejohn, G. Metabolic Factors in Diffuse Idiopathic Skeletal Hyperostosis—A Review of Clinical Data. Open Rheumatol. J. 2014, 8, 116–128. [Google Scholar] [CrossRef] [Green Version]
- Lantsman, C.D.; Herman, A.; Verlaan, J.J.; Stern, M.; Mader, R.; Eshed, I. Abdominal fat distribution in diffuse idiopathic skeletal hyperostosis and ankylosing spondylitis patients compared to controls. Clin. Radiol. 2018, 73, 910–915. [Google Scholar] [CrossRef] [PubMed]
Variable | |
---|---|
Sex, n (%) | |
Females | 41 (42.3) |
Males | 56 (57.7) |
Age at diagnosis, years | 65.6 (9.5) |
Age at onset, years | 58.2 (9.0) |
Comorbidities, n (%) | |
Type 2 diabetes | |
Yes | 24 (25.0) |
No | 72 (75.0) |
Dyslipidaemia | |
Yes | 35 (36.5) |
No | 61 (63.5) |
CVE 1 | |
Yes | 11 (11.5) |
No | 85 (88.5) |
AHT 2 | |
Yes | 49 (51.0) |
No | 47 (49.0) |
Resnick criteria, n (%) | |
Yes | 70 (72.2) |
No | 27 (27.8) |
Utsinger criteria, n (%) | |
Definite | 70 (72.2) |
Probable | 20 (20.6) |
Possible | 7 (7.2) |
Presenting symptoms, n (%) | |
Pain/limitation TS 3/LS 4 | 42 (43.8) |
Enthesitis | 23 (24.0) |
Radiological findings | 10 (10.4) |
Hip pain/limitation | 5 (5.2) |
Pain/limitation CS 5 | 16 (16.7) |
Enthesitis, n (%) | |
Yes | 39 (40.2) |
No | 58 (59.8) |
Patterns, n 68 (%) | |
Peripheral | 20 (29.4) |
Axial | 21 (30.9) |
Mixed | 27 (39.7) |
Axial involvement n (%) | |
CS 5 (n = 64) | |
Affected | 37 (57.8) |
Not affected | 27 (42.2) |
TS 3 (n = 92) | |
Affected | 85 (92.4) |
Not affected | 7 (7.6) |
LS 4 (n = 89) | |
Affected | 50 (56.2) |
Not affected | 39 (43.8) |
Extraspinal involvement, n (%) | |
Elbow [olecranon] (n = 44) | |
Affected | 30 (68.2) |
Not affected | 14 (31.8) |
Hip [acetabular excrescences] (n = 82) | |
Affected | 42 (51.2) |
Not affected | 40 (48.8) |
Major Trochanter (n = 80) | |
Affected | 65 (81.3) |
Not affected | 15 (18.8) |
Knees (sup/inf patella, tibial tuberosity) (n = 65) | |
Affected | 43 (66.2) |
Not affected | 22 (33.8) |
Achilles tendon insertion (n = 54) | |
Affected | 43 (79.6) |
Not affected | 11 (20.4) |
Plantar calcaneus (n = 52) | |
Affected | 39 (75.0) |
Not affected | 13 (25.0) |
PATTERNS TYPE | PP | AP | MP | p-Value | |||
---|---|---|---|---|---|---|---|
Age Dg 1, years (n/mean/SD) | 20 | 62.05 (11.81) | 21 | 68.14 (8.76) | 27 | 66.30 (8.19) | 0.119 |
Age at onset, years (n/mean/SD) | 17 | 53.88 (5.31) # | 15 | 60.53 (10.27) | 21 | 60.05 (7.36) # | 0.036 |
Sex (n/%) | 0.004 | ||||||
Females | 14 | 70.0% a | 4 | 19.0% b | 10 | 37.0% a,b | |
Males | 6 | 30.0% a | 17 | 81.0% b | 17 | 63.0% a,b | |
Diagnostic delay, years (n/mean/SD) | 17 | 5.53 (8.83) | 15 | 7.33 (8.16) | 21 | 6.52 (8.24) | 0.832 |
Comorbidities (n/%) | |||||||
Type 2 diabetes | 0.419 | ||||||
Yes | 3 | 15.8% | 7 | 33.3% | 8 | 29.6% | |
No | 16 | 84.2% | 14 | 66.7% | 19 | 70.4% | |
Dyslipidaemia | 0.739 | ||||||
Yes | 6 | 31.6% | 9 | 42.9% | 11 | 40.7% | |
No | 13 | 68.4% | 12 | 57.1% | 16 | 59.3% | |
CVE 2 | 0.001 | ||||||
Yes | 1 | 5.3% a,b | 7 | 33.3% b | 0 | 0.0% a | |
No | 18 | 94.7% a,b | 14 | 66.7% b | 27 | 100.0% a | |
AHT 3 | 0.123 | ||||||
Yes | 7 | 36.8% | 8 | 38.1% | 17 | 63.0% | |
No | 12 | 63.2% | 13 | 61.9% | 10 | 37.0% | |
Presenting symptom (n/%) | 0.007 | ||||||
Pain/limitation TS 4/LS 5 | 4 | 20.0% a | 10 | 47.6% a | 10 | 38.5% a | |
Clin enthesopathy | 11 | 55.0% a | 1 | 4.8% b | 9 | 34.6% a | |
Rx findings 6 | 1 | 5.0% a | 6 | 28.6% a | 1 | 3.8% a | |
Hip pain/limitation | 2 | 10.0% a | 1 | 4.8% a | 1 | 3.8% a | |
Pain/limitation CS 7 | 2 | 10.0% a | 3 | 14.3% a | 5 | 19.2% a | |
Clinical enthesopathy (n/%) | <0.001 | ||||||
Yes | 17 | 85.0% a | 5 | 23.8% b | 11 | 40.7% b | |
No | 3 | 15.0% a | 16 | 76.2% b | 16 | 59.3% b | |
Radiological findings (n/%) | |||||||
CS 7 (n = 45) | 0.020 | ||||||
Affected | 3 | 18.8% a | 6 | 60.0% a,b | 12 | 63.2% b | |
Not affected | 13 | 81.3% a | 4 | 40.0% a,b | 7 | 36.8% b | |
TS 4 (n = 63) | 0.059 | ||||||
Affected | 15 | 78.9% | 19 | 100.0% | 24 | 96.0% | |
Not affected | 4 | 21.1% | 0 | 0.0% | 1 | 4.0% | |
LS 5 (n = 63) | <0.001 | ||||||
Affected | 3 | 15.0% a | 12 | 66.7% b | 19 | 76.0% b | |
Not affected | 17 | 85.0% a | 6 | 33.3% b | 6 | 24.0% b | |
Hip (n = 63) | 0.035 | ||||||
Affected | 13 | 65.0% a | 5 | 26.3% b | 14 | 58.3% a,b | |
Not affected | 7 | 35.0% a | 14 | 73.7% b | 10 | 41.7% a,b |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Clavaguera, T.; Reyner, P.; Buxó, M.; Valls, M.; Armengol, E.; Juanola, X. Identifying Clinicoradiological Phenotypes in Diffuse Idiopathic Skeletal Hyperostosis: A Cross-Sectional Study. Medicina 2021, 57, 1005. https://doi.org/10.3390/medicina57101005
Clavaguera T, Reyner P, Buxó M, Valls M, Armengol E, Juanola X. Identifying Clinicoradiological Phenotypes in Diffuse Idiopathic Skeletal Hyperostosis: A Cross-Sectional Study. Medicina. 2021; 57(10):1005. https://doi.org/10.3390/medicina57101005
Chicago/Turabian StyleClavaguera, Teresa, Patrícia Reyner, Maria Buxó, Marta Valls, Eulàlia Armengol, and Xavier Juanola. 2021. "Identifying Clinicoradiological Phenotypes in Diffuse Idiopathic Skeletal Hyperostosis: A Cross-Sectional Study" Medicina 57, no. 10: 1005. https://doi.org/10.3390/medicina57101005